ESC 365 - Immune checkpoint inhibitors and atherosclerotic cardiovascular events: a retrospective cohort study

ESC Professional Premium Access

Immune checkpoint inhibitors and atherosclerotic cardiovascular events: a retrospective cohort study

Session: T-cells, checkpoint inhibitors, and cardiac complications

Topic: Cardio-Oncology

Speaker: Doctor S. Tan (Melbourne, AU)

Event: ESC Congress 2023

Congress Presentation

Add to my library

About the speaker

Doctor Sean Tan

Monash University, Melbourne (Australia)

2 presentations

0 follower

7 more presentations in this session

Cardiovascular complications of chimeric antigen receptor (CAR)-T cell therapy

Speaker: Associate Professor F. Guerra (Ancona, IT)

Atrial and ventricular arrhythmias with immune checkpoint inhibitor therapy in patients without evidence of myocarditis

Speaker: Doctor J. Heemelaar (Boston, US)

Arterial inflammation induced by immune checkpoint inhibitors assessed on 18F-FDG PET-CT scans in stage III/IV melanoma patients

Speaker: Miss E. Polomski (Leiden, NL)

Gender differences in cardio-oncology care of patients treated with immune checkpoint inhibitor therapy

Speaker: Associate Professor R. Mincu (Essen, DE)

Anti CTLA-4 and PD-1 monoclonal antibodies increases systemic SDF-1 and galectin-3 levels and reduces myocardial strain through NLRP3 and MyD-88 pathways

Speaker: Doctor N. Maurea (Naples, IT)

Access the full session

T-cells, checkpoint inhibitors, and cardiac complications

Speakers: Doctor S. Tan, Associate Professor F. Guerra, Doctor J. Heemelaar, Miss E. Polomski, Associate Professor R. Mincu...

About the event

ESC Congress 2023

25 August - 28 August 2023

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources